| Literature DB >> 31627453 |
Hossein Jahangirian1, Susan Azizi2, Roshanak Rafiee-Moghaddam3, Bahram Baratvand4, Thomas J Webster5.
Abstract
In recent decades, regenerative medicine has merited substantial attention from scientific and research communities. One of the essential requirements for this new strategy in medicine is the production of biocompatible and biodegradable scaffolds with desirable geometric structures and mechanical properties. Despite such promise, it appears that regenerative medicine is the last field to embrace green, or environmentally-friendly, processes, as many traditional tissue engineering materials employ toxic solvents and polymers that are clearly not environmentally friendly. Scaffolds fabricated from plant proteins (for example, zein, soy protein, and wheat gluten), possess proper mechanical properties, remarkable biocompatibility and aqueous stability which make them appropriate green biomaterials for regenerative medicine applications. The use of plant-derived proteins in regenerative medicine has been especially inspired by green medicine, which is the use of environmentally friendly materials in medicine. In the current review paper, the literature is reviewed and summarized for the applicability of plant proteins as biopolymer materials for several green regenerative medicine and tissue engineering applications.Entities:
Keywords: biomaterials; green scaffolds; plant proteins; tissue engineering
Year: 2019 PMID: 31627453 PMCID: PMC6843632 DOI: 10.3390/biom9100619
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1In vitro culture and in vivo implantation of cell-seeded scaffolds to generate new tissue.
Figure 2Attractive aspects of plant proteins for biomedical applications. 3D: three-dimensional.
A Comparison between properties of plant proteins and animal proteins. Data from Reference [20].
| Property | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Protein | Molecular Weight (kDa) | Isoelectric Point | Platform | Solubility | Wet Mechanical Properties | ||||||
| Micro/Nano Particles | Micro/Nano Fibers | Micro/Nano Film | Hydrogel | Water | Ethanol | Organic Solvents | |||||
| Soy | 25–120 | 4.5–4.8 | ✓ | ✓ | ✓ | ✓ | × | × | × | Good | |
| Zein | 19–25 | 6 | ✓ | ✓ | ✓ | × | × | ✓ | ✓ | Fair | |
| Wheat gluten | Gliadin | 25–55 | 6.5 | ✓ | ✓ | ✓ | × | × | ✓ | ✓ | Fair |
| Gluten | 35–100 | 6 | ✓ | ✓ | ✓ | × | × | × | × | Good | |
| Glutenin | 32–130 | 6.8–7.0 | ✓ | ✓ | ✓ | × | × | × | × | Good | |
| Collagen | 300 | 4.7 | ✓ | ✓ | ✓ | × | ✓ | ✓ | ✓ | Poor | |
| Silk | 250–450 | 3.8–3.9 | ✓ | ✓ | ✓ | × | × | × | ✓ | Excellent | |
|
| [ | [ | [ | [ | [ | [ | [ | [ | |||
Figure 3Different forms and morphological structures of scaffolds for biomedical applications.
Advantages and disadvantages of different scaffolds used in tissue engineering. Adapted from Reference [38].
| Scaffold Types | Advantages | Disadvantages |
|---|---|---|
| Porous | High porosity provides a proper environment for extracellular matrix (ECM) secretion and nutrient materials to cells. | Homogenous distribution of the cells is confined by a porous nature. |
| Fibrous | A highly microporous structure is best appropriate for adhesion, proliferation, and differentiation of cells. | Surface functionalization is needed to make the nanofibers of these scaffolds. |
| Hydrogel | Extremely biocompatible and controlled | Low mechanical strength |
| Microsphere | Easily produced with controlled physical features suitable for slow or rapid drug delivery. Provides greater cell attachment and migration characteristics. | Microsphere sintering approaches are sometimes not compatible to the cells and decreases cell viability. |
| Composite | Highly biodegradable and offer mechanical strength. | Acidic derivatives are generated upon degradation. |
| Acellular | Natural ECM is maintained and consequently normal anatomical features are retained. | Partial decellularization is |
The most recent cellular and acellular reported studies using various forms of scaffolds for tissue engineering (TE) applications.
| Scaffold Structure | Method | Cells/Factors/Animal Model | Type | TE | Ref |
|---|---|---|---|---|---|
| Collagen and denatured collagen (DCol) | Solution casting-freezing-thawing | Rabbit chondrocytes seeding | 3D porous | Cartilage | [ |
| Collagen (Col)/carbon | Freezing and lyophilization | - | 3D porous | Bone | [ |
| Poly(lactic acid) (PLLA)/ polycaprolactone (PCL), and collagen type I | Freeze-drying | Adipose tissue-derived mesenchymal stem cells seeding | 3D porous | Skin | [ |
| Silk fibroin | Freezing | - | 3D porous (sponge) | - | [ |
| Decellularized extracellular matrix (dECM)/gelatin/chitosan | - | Bone marrow mesenchymal stem cell (BMSC) seeding | Porous | Meniscus | [ |
| Collagen/dECM/silk fibroin (SF) | 3D printing | Pre-osteoblast MC3T3-E1 cells | 3D micro-nanoporous | Bone | [ |
| Collagen | 3D Cell-printing | MC3T3-E1 | 3D porous | - | [ |
| Collagen type I/agarose with sodium alginate | 3D printing | Primary chondrocytes | 3D porous hydrogel | Cartilage | [ |
| α-TCP/collagen | 3D printing combined with a cell-printing | MC3T3-E1 cells | 3D porous | Bone | [ |
| Polycaprolactone/polyvinyl acetate (PCL/PVAc)/poly(lactic-co-glycolic acid)- one morphogenetic protein 2 (PLGA-BMP2) | Electrospinning and electrospraying | Osteogenic and osteoconductive markers (OCN and OPN) | 3D porous core-shell | Bone | [ |
| Hydroxyapatite/gelatin-chitosan | Coaxial electrospinning | Human osteoblast like cell line (MG-63) | 3D porous nanofibers | Bone | [ |
| Polycaprolactone (PCL) nanofibres/poly (lactic-co-glycolicacid) (PLGA) particles | Electrospinning | - | 3D porous nanofibers | Bone | [ |
| Hydroxyapatite (HA), 5CuHA and 5MgHA | Sol-gel and physio-chemical mixing | - | 3D porous fibers | Bone | [ |
| Chitosan/Sodium β-glycerophosphate/Gelatin (Cs/GP/Gel) | Freeze-drying | P3 bone mesenchymal stem cells (BMSCs) | 3D porous | Cartilage | [ |
| Polyurethane (PU), rosemary (RM) oil, and copper sulphate (CuSO4) | Electrospinning | Fibroblast cells | Two-dimensional (2D) porous nanofiber | Bone | [ |
| Chitosan (CS)/nano-hydroxyapatite (n-HAP) | Solution casting/Freeze-drying | MC3T3-E1 cells | Porous polymer/bioceramic | Bone | [ |
| Alginate/gelatin/nano-hydroxyapatite (n-HAP) | - | MG63 cells | Hydrogel | Bone | [ |
| Chitosan-gelatin (CS-Gel)/graphene oxide (GO) and Montmorillonite (MMT) | Freeze-drying | Human osteoblast cells | Porous | Bone | [ |
| Gelatin, alginate, and poly (vinyl alcohol)/silver hydroxyapatite | Cryogelation | MC3T3-E1 | 3D porous spongy | Bone | [ |
| Chitosan/alginate/hydroxyapatite/nanocrystalline cellulose | Freeze-drying | Fibroblast cells | 3D porous | Bone | [ |
| Bacterial cellulose (BC)/magnetite (Fe3O4)/hydroxyapatite (HA) nanoparticles | Ultrasonic irradiation | Mouse fibroblast L929 cells and osteoblast | 3D microporous | Bone | [ |
| Nipple-areolar complex (NAC) tissue | Decellularization | Bone marrow-derived mesenchymal | Acellular | NAC | [ |
| Decellularized myocardium extracellular matrix (ECM) and chitosan (CS) | Frozen and lyophilized | Human cardiac progenitor cells (hCPCs) | 3D macroporous cardiac | Myocardial | [ |
| Decellularized pig oesophagi | Decellularization | Human aortic smooth muscle cells (hASMCs) or human adipose-derived stem cells (hASCs) | Esophageal acellular | Esophageal muscle layers | [ |
| Acellular spinal | Decellularization | Rat bone marrow mesenchymal stem cells/Neurotrophic factor 3 (NT-3) | Acellular spinal | Spinal cord | [ |
| Human dura mater | Acellularized | - | Acellular dura mater | - | [ |
| Poly(ethylene glycol) (PEG/poloxamer) (P407) | Photo-polymerization | Wistar rat thigh | Hydrogel | Artificial cornea periphery | [ |
| Poly(ethyleneglycol)-poly(N-isopropylacrylamide) (PEGPNIPAAm), /poly(e-caprolactone) (PCL) | Free-radical polymerization | Human mesenchymal stem cells (hMSCs) | Hydride hydrogel | Cartilage | [ |
| 1% collagen microspheres and 0.3% collagen bulk | - | Human umbilical vein endothelial cells (HUVECs)/Eight-week old male C57/BL6 mice | Microspheres hydrogel | Dermal | [ |
| Methacrylathed pullulan | Multiscale light assisted 3D printing | Epithelial and | 2D and 3D hydrogel | - | [ |
| Silk fibroin (SF)/gelatin/bacterial | 3D printing and lyophilization | L929 cells | Hydrogel | - | [ |
| Chitosan/silk (particles, micro and nanofibers) | 3D printing | Human fibroblasts | Hydrogel | soft tissue | [ |
Figure 4A schematic of different plant protein treatments.
Figure 5Different fabrication methods for producing scaffolds.
Comparison of mechanical properties of soy protein fibers with other non-crosslinked plant protein fibers.
| Fiber | Strength, MPa | Elongation, % | Modulus, GPa | Ref. |
|---|---|---|---|---|
| Soy protein | 145 ± 10 | 8 ± 2 | 6.5 ± 1.7 | [ |
| Zein | 36 ± 60 | 1.8 ± 5.0 | - | [ |
| Wheat gluten | 115 ± 7 | 23 ± 2.7 | 5 ± 0.2 | [ |
| Gliadin | 120 ± 10 | 25 ± 3.2 | 4.2 ± 0.4 | [ |
Mechanical properties of soy protein isolate (SPI) fibrous scaffolds for skin tissue regeneration.
| SPI Fibrous Scaffolds | Method | Tensile Strength (MPa) | Young’s Modulus | Elongation (%) | Ref. |
|---|---|---|---|---|---|
| SPI (7 wt.%)/PEO(3wt.%) | ES | 0.06 ± 0.01 | 110 ± 6 KPa | - | [ |
| SPI (12 wt.%)/PEO(3wt.%) | ES | 0.17 ± 0.006 | 171 ± 21 KPa | - | [ |
| Hydrated SPI (5, 6, 7, 8%)/PEO (0.05%) | ES | 0.1 | - | - | [ |
| SPI (10 wt.%)/PEO(4 wt.%) (40:60) | ES | 2.3 | - | 9 | [ |
| Soy protein fiber | WS | 145 ± 10 | 6.5 ± 1.7 GPa | 8 ± 2 | [ |
NOTE. ES: Electrospinning and WS: Wet spinning.
Studies using soy protein-based matrices/scaffolds for tissue engineering (TE) applications.
| Scaffold Structure | TE Application | Method | Encapsulated/Seeded Cell Type (Source) | Animal Model | Ref |
|---|---|---|---|---|---|
| SPI/micron-sized 45S5 bioactive | - | Electrospinning | Mouse embryonic fibroblast (MEF) cells | - | [ |
| Tetracycline-loaded alginate/soy protein isolate (TCH-Alg/SPI)/polycaprolactone (PCL) | - | Co-axial electrospinning | Human dermal fibroblasts | - | [ |
| Soy protein modified bacterial cellulose (BC) | bone | Electrospinning, ultrasound-induced self-assembly | MG-63 cells | - | [ |
| Hydroxypropyl chitosan (HPCS)/soy protein isolate (SPI) | Skin | Crosslinking, solution casting, and evaporation | L929 cells | Rat | [ |
| Ethylene glycol diglycidyl ether (EGDE)-crosslinked hydroxyethyl cellulose (HEC)/soy protein isolate (SPI) | Skin | Blending, crosslinking and freeze-drying | L929 cells | - | [ |
| Soy protein isolate/bioactive glass | Skin | Solvent-casting | Mouse embryonic fibroblast (MEF) cells | - | [ |
Studies using zein protein-based matrices/scaffolds for tissue engineering (TE) applications.
| Scaffold Structure | TE Application | Method | Encapsulated/Seeded Cell Type (Source) | Animal Model | Reference |
|---|---|---|---|---|---|
| PCL/zein/gum | Skin | Electrospinning | Fibroblast L929 cell | - | [ |
| PCL/zein/GA/Calendula officinalis | Skin | Suspension, multilayer and two-nozzle electrospinning | Fibroblast L929 cell | - | [ |
| Zein/(PSS-modified HAP) nanoparticles | Bone | - | MG-63 cell | - | [ |
| HAP/zein | Bone | Solvothermal | Mouse bone marrow mesenchymal stem cells (MSCs) | - | [ |
| Zein/chitosan/nanohydroxyapatite (nHAP) | Bone | Freeze-drying | MG-63 cell | - | [ |
| PCL/zein coated 45S5 bioactive glass | Bone | Foam replication | - | - | [ |
| Poly(ε-caprolactone)-thermoplastic zein/hydroxyapatite particles | Bone | scCO2 foaming | Osteoblast-like MG63 and hMSCs | - | [ |
| Zein/calcium phosphate | Bone | Electrospinning/biomimetic mineralization process | Adipose-derived stem cells (ASCs) | [ | |
| rhBMP-2-loaded silica/HACC/zein | Bone | Solvent casting/Salt-leaching | hMSCs | - | [ |
| Zein films | - | Solvent casting | Human liver cells (HL-7702) and mice fibroblast cells (NIH3T3) | - | [ |
| CdS /zein | - | Electrospinning | MSCs and fibroblasts | - | [ |
| Zein | Bone | Salt-leaching | MSCs | Rabbit | [ |
| Zein/oleic acid | Bone | Salt-leaching porogen (Mannitol) | MSCs | Rabbit | [ |
| PLGA/HAP/zein | Cartilage | Electrospinning | hUC-MSCs | - | [ |
| Zein | Bone | - | HUVECs and MSCs | Rabbit | [ |
| Zein polydopamine/bone morphogenic protein-2 (BMP-2) peptide | Bone | Electrospinning | Human fetal osteoblast | - | [ |
| Zein/45S5 bioactive glass | Bone | Salt leaching | - | - | [ |
| Zein/PLLA | Bone | Electrospinning | MSCs | - | [ |
| Zein/gelatin | - | Electrospinning | Human periodontal ligament stem cells | - | [ |
| Zein/gelatin | - | Force-spinning | Human fibroblasts | - | [ |
| Poly(ε-caprolactone) (PCL)/zein | - | Electrohydrody- namic printing | Mice embryonic fibroblast (NIH/3T3) and human non small lung cancer cell (H1299) | - | [ |
| Zein/silver-doped bioactive glass | Bone | - | MG-63 cells | - | [ |